Tag: Cardiac disease

According to a 2020 study, induction of labor with a slow oxytocin infusion was found to be a relatively safe procedure for women with low-risk heart disease, but this does not universally negate the need for caution in all cardiac patients. The decision of whether to administer oxytocin and how to do so depends on a careful, individualized assessment of the patient's specific cardiac condition and overall risk profile.

According to the National Institutes of Health, ergometrine is explicitly contraindicated in patients with coronary artery disease and other hypertensive disorders due to its potent vasoconstrictive properties. Understanding why is ergometrine contraindicated in cardiac disease is crucial for medical professionals to prevent severe and potentially fatal cardiovascular events.